Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R15DK082800 | U.S. NIH Grant/Contract | View source | |
| M01RR024986 | Other Grant/Funding Number | Michigan Institute of Clinical and Health Research |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Wisconsin, La Crosse | OTHER |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
Not provided
Not provided
Not provided
Not provided
The two specific aims of the study were to determine whether:
The study addresses the problem that postmenopausal women with type 2 diabetes have a higher incidence of bone breaks despite their often normal bone mineral density (BMD).
The investigators pursued two hypotheses, that:
Subjects were 15 postmenopausal women with type 2 diabetes, age 57.7 years, BMI 27.2 kg/m2 who were randomly assigned to two out of 5 trials:
Uphill exercise before the meals (UBM), Uphill exercise after the meals (UAM), Downhill exercise before the meals (DBM), Downhill exercise after the meals (DAM), and Sedentary, no-exercise, trial (SED). All subjects signed an informed consent approved by the University of Michigan Medical School Institutional Review Board. Subjects had their BMD measured with DXA at the outset.
Weight-maintenance meals contained 50% carbohydrate, 15% protein, and 25% fat and were provided at 10 h and 17 h. Exercise (40 minutes at 50% of maximal effort) on either uphill (+6o slope) or downhill treadmill (-6o slope) was performed either before the two meals, at 9 h and 16 h, respectively, or after the meals. at 11 h and 18 h, respectively.
Blood was drawn through an intravenous catheter from ante-cubital vein at hourly intervals between 8 and 20 h with two additional blood draws at 0 h and 6 h the next morning. Blood was treated with protease inhibitors, and plasma, frozen at -80o C, was used to measure bone markers, CICP, CTX, osteocalcin , and bone-specific alkaline phosphatase using Millipore chemoluminescen reagents, glucose by glucose oxidase, and hormones insulin, cortisol, parathyroid hormone (PTH) , and growth hormone (GH) by radio-immunoassays..
Mixed-model ANOVA was used for analysis of outcome measures where the trial procedures served as fixed variable and individual subjects as intercept variables.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Uphill exercise before the meals | Experimental | 40 minutes of uphill treadmill exercise at +6o slope completed 1 hour before eating the meal |
|
| Uphill exercise after the meals | Experimental | 40 minutes of uphill treadmill exercise at +6o slope started 1 hour after eating the meal |
|
| Downhill exercise before the meals | Experimental | 40 minutes of downhill treadmill exercise at -6o slope completed 1 hour before eating the meal |
|
| Downhill exercise after the meals | Experimental | 40 minutes of downhill treadmill exercise at -6o slope started 1 hour after eating the meal |
|
| Sedentary trial | Sham Comparator |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Behavior intervention of uphill exercise | Combination Product | 40 minutes of uphill exercise |
|
| Measure | Description | Time Frame |
|---|---|---|
| C-terminal propeptide of type I collagen | Change over time in plasma concentration of c-terminal propeptde of type 1 collagen (ng/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| C-terminal telopeptide of type 1 collagen | Change over time in plasma concentration of c-terminal telopeptide of type 1 collagen (ng/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Osteocalcin | Change over time in plasma concentration of osteocalcin (ng/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Bone-specific alkaline phosphatase | Change over time in plasma concentration of bone-specific alkaline phosphatase (ng/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Measure | Description | Time Frame |
|---|---|---|
| Insulin | Change over time in plasma concentration of insulin (µU/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Parathyroid hormone |
Not provided
Inclusion Criteria:
postmenopausal type-2 diabetes melllitus age between 50 and 65 exercise less than 20 minutes three times a week
Exclusion Criteria:
metabolic disease other than type-2 diabetes and hormonally-corrected hypothyroidism musculo-skeletal disability that would preclude exercise smoker do not meet inclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Katarina T Borer | Professor Emerita | Principal Investigator |
Not provided
Not provided
Study consisted of 5 experimental trials (or arms), of which 4 were compared to a sedentary (or control) arm. The five trials were: Uphill exercise before the meals (UBM), Uphill exercise after the meals (UAM), Downhill exercise before the meals (DBM), and Downhill exercise after the meals (DAM), and the Sedentary (Sed) or control trial.
Not provided
Not provided
Not provided
Not provided
A trial with no exercise |
|
| Dietary intervention of exercise before the meal | Combination Product | 40 minutes of uphill exercise completed 1 h before the meal |
|
| Dietary intervention of uphill exercise | Combination Product | 40 minutes of uphill exercise |
|
| Dietary intervention of exercise after the meal | Combination Product | 40 minutes of uphill exercise started 1 hour after gthe meal |
|
| Behavior intervention of downhill exercise | Combination Product | 40 minutes of downhill exercise |
|
| Dietary intervention of exercise before the meal | Combination Product | 40 minutes of downhill exercise completed 1 hour before the meal |
|
| Behavioral intervention of downhill exercise | Combination Product | 40 minutes of downhill exercise |
|
| Dietary intervention of exercise after the meal | Combination Product | 40 minutes of downhill exercise started 1 hour after the meal |
|
| Behavioral intervention of sedentary no-exercise trial | Combination Product | Sedentary no-exercise trial |
|
| Dietary intervention of eating two meals | Combination Product | Meals eaten at 10 and 17 h during a sedentary trial |
|
Change over time in plasma concentration of parathyroid hormone (ng/ml)
| Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Cortisol | Change over time in plasma concentration of cortisol (m/L) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Growth hormone | Change over time in plasma concentration of growth hormone (ng/ml) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Glucose | Change over time in plasma concentration of glucose (mg/dl) | Hourly over 12 hours from the start of the trial, then at 16 hours, and at 22 hours, after the start of the trial |
| Dual-energy X-ray radiography | Whole-body dual-energy X-ray radiography scan | A week prior to the study baseline |
| Novel Pedar | Mechanosensitive shoe inserts for measurement of ground reaction force | During two one-hour bouts of the exercise intervention |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided